Evaluation of medical quality and treatment trends of nonvalvular atrial fibrillation in Beijing inpatients

被引:1
|
作者
Yu, Hai-Rong [1 ,2 ]
Ma, Chang-Sheng [1 ]
Du, Xin [1 ]
Chang, San-Shuai [1 ]
Dong, Jian-Zeng [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Natl Clin Res Ctr Cardiovasc Dis,Dept Cardiol, Beijing Adv Innovat Ctr Big Data Based Precis Med, 2 Anzhen Rd, Beijing 100029, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Cardiovasc Ctr, Beijing, Peoples R China
关键词
Atrial fibrillation (AF); performance measure (PM); quality measure (QM); compliance; MANAGEMENT; RISK; GUIDELINES; HEART; CHINA;
D O I
10.21037/apm-20-1925
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The quality of care presented to AF cases in tertiary and non- tertiary hospitals in China remains obscure and needs further investigation. Therefore, we examined the compliance with quality measures (QMs) and clinical performance measures (PMs) that were proposed by the ACC/AHA in 2016 in a Chinese adult population with nonvalvular atrial fibrillation (AF). We also investigated the changes in patients' characteristics, treatment plans, and quality of provided care at different time-points [2011-2016]. Methods: We used the datasets from two registry-based studies in Beijing, including the Chinese Atrial Fibrillation Registry (CHINA-AF) investigation. From August 2011 to July 2016, an overall number of 13,439 nonvalvular AF cases were included. Our primary outcome was to determine the compliance rate with two PMs [oral anticoagulant (OAC) use and prothrombin time international normalized ratio (INR)] and six QMs (beta-blocker, ACEI-ARB, and the inappropriate prescription of antiarrhythmic drugs, Sotalol, antiplatelet and OAC, and non-dihydropyridine calcium channel antagonist) over a period of 5 years [20112016]. Also, the difference in compliance between tertiary and non-tertiary hospitals was investigated. Results: The compliance with PMs and QMs was variable between tertiary and non-tertiary hospitals. In tertiary hospitals, the total number of inpatient beds was >500, and each bed was equipped with >1.03 health technical personnel and >0.4 nurses. In non-tertiary hospitals, the available beds capacity was <500, and each bed corresponded with 0.7-0.88 health technical personnel and >0.4 nurses. The compliance rates with OAC use steadily increased from 2011-2015 in tertiary hospitals (35%, 35.9%, 37.9%, 45%, and 49%, P<0.001). In non-tertiary hospitals, INR follow-up of warfarin use increased significantly over the years, with rates of 36.2%, 60.5%, 71.6%, 64.3%, and 81.5% (P=0.04), respectively. In terms of QMs, the compliance with the six measure sets was quite similar among tertiary and non-tertiary hospitals avoiding any significant difference over the years (P>0.05). Conclusions: We noted an improvement in medical quality regarding the use of OAC, especially in tertiary hospitals. Meanwhile, the compliance rates of INR follow-up improved in non-tertiary hospitals. However, the compliance rates of other performance and QMs are still low, which are in need of improvement.
引用
收藏
页码:5270 / +
页数:11
相关论文
共 50 条
  • [1] TREATMENT OF NONVALVULAR ATRIAL-FIBRILLATION
    STETTIN, GD
    WESTERN JOURNAL OF MEDICINE, 1995, 162 (04): : 331 - 339
  • [2] A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation
    Zheng, Xiao-Yuan
    Feng, Guang-Wei
    Guo, Jing
    Xie, Fen
    Li, Xia
    Zhang, Ming-Zhu
    Zhang, Xiu-Fen
    Wu, Xiu-Feng
    Ding, Yong-Juan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] Evaluation of antithrombotic treatment in institutionalized geriatric patients with nonvalvular atrial fibrillation
    Alaba-Trueba, Javier
    Arriola-Manchola, Enrique
    Ferro-Uriguen, Alexander
    Beobide-Telleria, Idoia
    Martinez-Arrechea, Silvia
    FARMACIA HOSPITALARIA, 2021, 45 (04) : 170 - 175
  • [4] The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China
    Zheng, Huan Jie
    Ouyang, Shu Kun
    Zhao, Yue
    Lu, Kai
    Luo, Su Xin
    Xiao, Hua
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2017, 10 : 69 - 77
  • [5] Anticoagulant treatment in nonvalvular atrial fibrillation there is room for improvement
    Garcia-Bragado Dalmau, F.
    REVISTA CLINICA ESPANOLA, 2015, 215 (02): : 98 - 99
  • [6] Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation
    Norby, Faye L.
    Alonso, Alvaro
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (06) : 549 - 560
  • [7] Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands
    Chen, Qingui
    Toorop, Myrthe M. A.
    Tops, Laurens F.
    Lijfering, Willem M.
    Cannegieter, Suzanne C.
    JAMA NETWORK OPEN, 2023, 6 (04) : e239973
  • [8] EVALUATION OF ANTICOAGULANT TREATMENT PATTERNS OF PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION DURING HOSPITALIZATION IN THE US
    Deitelzweig, Steven Bruce
    Dhamane, Amol
    Di Fusco, Manuela
    Russ, Cristina
    Rosenblatt, Lisa
    Mardekian, Jack
    Lingohr-Smith, Melissa
    Lin, Jay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 344 - 344
  • [9] New onset atrial fibrillation developing in medical inpatients
    Chen, S. X.
    Amir, K.
    Bobba, R.
    Arsura, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (05) : 810 - 811
  • [10] New Onset Atrial Fibrillation Developing in Medical Inpatients
    Chen, Sydney X.
    Amir, Khalil A.
    Bobba, Ravi K.
    Arsura, Edward L.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 337 (03): : 169 - 172